Ader, P, Wessmann, A & Wolffram, S (2000) Bioavailability and metabolism of the flavonol quercetin in the pig. J Free Radic Biol Med 28, 1056–1067.
Aziz, AA, Edwards, CA, Lean, MEJ & Crozier, A (1998) Absorption and excretion of conjugated flavonols, including quercetin-4′-O-beta-glucoside and isorhamnetin-4′-O-beta-glucoside by human volunteers after the consumption of onions. Free Radic Res 29, 257–269.
Beretz, A, Cazenave, JP & Anton, R (1982) Inhibition of aggregation and secretion of human-platelets by quercetin and other flavonoids – structure activity relationships. Agents Actions 12, 382–387.
Bovy, AG, de Vos, CHR, Kemper, M, Almenar, Pertejo M, Muir, SR, Collins, GJ, Robinson, S, Verhoeyen, ME, Hughes, SG & van Tunen, AJ (2002) High-flavonol tomatoes through heterologous expression of the maize transcription factor genes LC and C1. lant Cell 14, 2509–2526.
Cicmil, M, Thomas, JM, Leduc, M, Bon, C & Gibbins, JM (2002) PECAM-1 signalling inhibits the activation of human platelets. Blood 99, 137–144.
Conquer, JA, Maiani, G, Azzini, E, Raguzzini, A & Holub, BJ (1998) Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 128, 593–597.
de Pascual-Teresa, S, Johnston, KL, DuPont, MS, O'Leary, KA, Needs, PW, Morgan, LM, Clifford, MN, Bao, YP & Williamson, G (2004) Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J Nutr 134, 552–557.
Duffy, SJ, Vita, JA, Holbrook, M, Swerdloff, PL & Keaney, JF (2001) Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21, 1084–1089.
Femia, AP, Caderni, G, Ianni, M, Salvadori, M, Schijlen, E, Collins, G, Bovy, A & Dolora, P (2003) Effects of diets fortified with tomatoes or onions with variable quercetin-glycoside content on azoxymethane-induced aberrant crypt foci in the colon of rats. Eur J Nutr 42, 346–352.
Formica, JV & Regelson, W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33, 1061–1080.
Gibbins, JM, Okuma, M, Farndale, R, Barnes, M & Watson, SP (1997) Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain. FEBS Letters 413, 255–259.
Gosnay, S, Bishop, J, New, S, Bishop, S, Catterick, J & Clifford, M (2002) Estimation of the mean intakes of 14 classes of dietary phenols in a population of young British women aged 20–30 years. Free Radic Res 36, 115–116.
Hertog, MGL, Feskens, EJM, Hollman, PCH, Katan, MB & Kromhout, D (1993) Dietary antioxidant flavonoids and risk of coronary heart-disease – the Zutphen Elderly study. Lancet 342, 1007–1011.
Hertog, MGL, Hollman, PCH & Katan, MB (1992) Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40, 2379–2383.
Hertog, MG, Kromhout, D, Aravanis, C, Blackburn, H, Buzina, R, Fidanza, F, Giampaoli, S, Jansen, A, Menotti, A & Nedeljkovic, S (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Int Med 155, 381–386.
Hertog, MGL, Sweetman, PM, Fehily, AM, Elwood, PC & Kromhout, D (1997) Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 65, 1489–1494.
Hodgson, JM, Puddey, IB, Burke, V, Beilin, LJ, Mori, TA & Chan, SY (2002) Acute effects of ingestion of black tea on postprandial platelet aggregation in human subjects. Br J Nutr 87, 141–145.
Hollman, PCH, Bijsman, M, van Gameren, Y, Cnossen, EPJ, de Vries, JHM & Katan, MB (1999) The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 31, 569–573.
Hollman, PCH, Hertog, MGL & Katan, MB (1996) Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochem Soc Trans 24, 785–789.
Hubbard, GP, Stevens, JM, Cicmil, M, Sage, T, Jordan, PA, Williams, CM, Lovegrove, JA & Gibbins, JM (2003) Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components, of the glycoprotein VI signaling pathway. J Thromb Haemost 1, 1079–1088.
Hubbard, GP, Wolffram, S, Lovegrove, JA & Gibbins, JM (2004) Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2, 2138–2145.
Janssen, P, Mensink, RP, Cox, FJJ, Harryvan, JL, Hovenier, R, Hollman, PCH & Katan, MB (1998) Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 67, 255–262.
Keevil, JG, Osman, HE, Reed, JD & Folts, JD (2000) Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 130, 53–56.
Landolfi, R, Mower, RL & Steiner, M (1984) Modification of platelet-function and arachidonic-acid metabolism by bioflavonoids-structure activity relations. Biochem Pharmacol 33, 1525–1530.
McAnlis, GT, McEneny, J, Pearce, J & Young, IS (1999) Absorption and antioxidant effects of quercetin from onions, in man. Eur J Clin Nutr 53, 92–96.
Manach, C, Regerat, F, Texier, O, Agullo, G, Demigne, C & Remesy, C (1996) Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids. Nutr Res 16, 517–544.